TrianglePUBLICATIONS · 19188680
Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2009 Mar 10
- First author
- Reck M
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 May 10;27(14):2415
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
Authors and identifiers
- name
- Reck M
- type
- Author
- name
- von Pawel J
- type
- Author
- name
- Zatloukal P
- type
- Author
- name
- Ramlau R
- type
- Author
- name
- Gorbounova V
- type
- Author
- name
- Hirsh V
- type
- Author
- name
- Leighl N
- type
- Author
- name
- Mezger J
- type
- Author
- name
- Archer V
- type
- Author
- name
- Moore N
- type
- Author
- name
- Manegold C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Reck M
- type
- Author
- name
- von Pawel J
- type
- Author
- name
- Zatloukal P
- type
- Author
- name
- Ramlau R
- type
- Author
- name
- Gorbounova V
- type
- Author
- name
- Hirsh V
- type
- Author
- name
- Leighl N
- type
- Author
- name
- Mezger J
- type
- Author
- name
- Archer V
- type
- Author
- name
- Moore N
- type
- Author
- name
- Manegold C
- type
- Author
- bibliography ids
- nci-bib-626c6e02faa4db25c75c30b7
- book metadata
- content sha256
- fe88453c31858c6408092d4578d277ac5540b07cd919547a1eabbcfcc16561d1
- document type
- citation
- dois
- 10.1200/JCO.2007.14.5466
- electronic publication date
- display
- 2009 Feb 2
- precision
- day
- year
- 2009
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:19188680
- immutable id
- pubmed:19188680@fe88453c31858c6408092d4578d277ac5540b07cd919547a1eabbcfcc16561d1
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 8
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1227-34
- volume
- 27
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2009 May 10;27(14):2415
- note
- Source null
- related pmid
- Source null
- relationship
- Erratum in
- url
- Source null
- outcomes validated
- false
- pmid
- 19188680
- provenance
- batch id
- 27a383f06e5fc3d04fad
- provider
- NCBI PubMed ESummary
- record sha256
- 5e1abf1a20b83e8924bc008455c30a8d935f550c5b56413c6c60c3e45f5d4461
- response sha256
- 51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
- retrieved at
- 2026-09-09T23:46:24.265787+00:00
- publication date
- display
- 2009 Mar 10
- precision
- day
- year
- 2009
- publication types
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil.
Preserved source evidence · Not medical advice